Two-year persistence of golimumab as second-line biologic agent in rheumatoid arthritis as compared to other subcutaneous tumor necrosis factor inhibitors: real-life data from the LORHEN registry.
| Image |  |
|---|---|
| Description | scientific article published on 30 October 2017 |
| Author/s |
author: Andrea Becciolini Ennio Giulio Favalli Roberto Caporali Chiara Bazzani Enrico Fusaro Vittorio Grosso Roberto Gorla Luigi Sinigaglia Fabiola Atzeni Raffaele Pellerito |
| Publication date | October 30, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |